New cancer drug enters first human trials for advanced tumors
Disease control
Recruiting now
This is the first time a new cancer drug called ASKC202 is being tested in people. The study aims to find a safe dose and see how the body processes the drug, both alone and when combined with another drug called ASK120067. It will enroll about 150 adults with advanced solid tumo…
Phase: PHASE1 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC